As of 2024-12-13, the Fair Value of Jounce Therapeutics Inc (JNCE) is -4.84 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.88 USD, the upside of Jounce Therapeutics Inc is -357.28%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 5Y Avg | |
| Net income | -27.40 | 56.80 | -43.80 | -90.87 | -50.92 | -31.24 |
| YoY growth | -67.07% | 307.30% | -177.11% | -107.47% | 43.97% | -0.08% |
| Market Cap (mil) | 98.95 |
| P/E | |
| Forward P/E |
| EPS | -0.97 |
| Avg earnings growth rate | -0.08% |
| TTM earnings | -50.92 |